Healthcare | April 02, 2024
Vivity reaches 1 million milestone
Vivity is the first and only wavefront-shaping IOL with Alcon’s proprietary X-WAVE Technology
Vivity is the first and only wavefront-shaping IOL with Alcon’s proprietary X-WAVE Technology
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 21, 2024
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
Additional capacity broadens Grace’s fine chemical capabilities for API production
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
Combines biocompatibility, heat-resistance, transparency and durability
Subscribe To Our Newsletter & Stay Updated
